10 March 2026
Exclusive Interview: Dr Ee Xien Ng, Technical Expert, APAC, BioReliance® Contract Testing Services, Advanced Solutions, Merck Life Science | ADC Asia Congress 2026
Dr. Ee Xien Ng from Merck explains how Next-Generation Sequencing (NGS) is enabling deeper genomic insights to support safer biomanufacturing decisions, helping complex modalities such as ADCs move confidently toward GMP manufacturing while keeping pace with evolving regulatory expectations.
Download the Full White Paper Here!
Download the Full e-Book Here!
DownloadDownload the Full Interview Here!
DownloadSubscribe For News Updates
Subscribe to the IMAPAC Newsletter to stay informed of the latest news in the biopharmaceutical industry.
